Literature DB >> 28003043

Genetic impact on the treatment & management of Hirschsprung disease.

Sam W Moore1.   

Abstract

BACKGROUND: The identification of Hirschsprung's disease (HD) as a genetic condition has been a major step forward in understanding the development of the enteric nervous system and conditions arising from ganglion cell maldevelopment.
METHOD: A study of the role of genetics in HD was carried out based on previously published findings from more than 400 cases of HD.
RESULTS: There are at least 7 pertinent clinical questions related to HD which were further investigated. These included: diagnosis, familial recurrence, long segment and total colonic aganglionosis, syndromic associations, the question of HD-associated enterocolitis, potential causes of postoperative obstructive symptoms after successful surgery, and the apparent low prevalence in premature infants. This review aimed at evaluating the most important concepts of where we have got to in our understanding of where genetic solutions/directions to these clinical problems might lie. Possible genetic reasons for the low prevalence in premature infants was also considered and the possible plasticity of the ENS at that stage as a potential "door of hope" in the future management of HD.
CONCLUSION: The study of genetics has made a massive contribution to the understanding and management of HD. It opens a "door of hope" to the future management of the condition. LEVEL OF EVIDENCE: Level V.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelin-B receptor gene; Hirschsprung's disease; MEN2 syndrome; RET proto-oncogene; Total colonic aganglionosis

Mesh:

Substances:

Year:  2016        PMID: 28003043     DOI: 10.1016/j.jpedsurg.2016.11.012

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

Review 1.  Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR).

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2018-09-14       Impact factor: 1.827

2.  The challenges of closing an ileostomy in patients with total intestinal aganglionosis after small bowel transplant.

Authors:  Fereshteh Salimi Jazi; Tiffany J Sinclair; Chad M Thorson; Ricardo Castillo; Andrew C Bonham; Carlos O Esquivel; Matias Bruzoni
Journal:  Pediatr Surg Int       Date:  2017-11-23       Impact factor: 1.827

3.  Clinical significance and biological effect of ZFAS1 in Hirschsprung's disease and preliminary exploration of its underlying mechanisms using integrated bioinformatics analysis.

Authors:  Yujiao Wang; Peng Cai; Jian Wang
Journal:  Ir J Med Sci       Date:  2022-01-06       Impact factor: 1.568

4.  Delayed appearance of mature ganglia in an infant with an atypical presentation of total colonic and small bowel aganglionosis: a case report.

Authors:  Fereshteh Salimi Jazi; Julia M Chandler; Chad M Thorson; Tiffany J Sinclair; Florette K Hazard; John A Kerner; Sanjeev Dutta; James C Y Dunn; Stephanie D Chao
Journal:  BMC Pediatr       Date:  2019-04-05       Impact factor: 2.125

5.  Prevalence of Hirschsprung-associated enterocolitis in patients with Hirschsprung disease.

Authors:  J Hagens; K Reinshagen; C Tomuschat
Journal:  Pediatr Surg Int       Date:  2021-09-30       Impact factor: 1.827

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.